Health Catalyst, Inc.
HCAT Nasdaq· Services-Computer Programming, Data Processing, Etc.
Last close · Oct 23, 2026
$1.69
KIRA · Stoqly’s AI analyst, in plain words
- Health Catalyst, Inc. had $311M of revenue in fiscal 2025, up 1.5% on the year before. Over five years, revenue changed +10.5% a year on average.
- Its operating margin was −51.7%, down 28.9 pts: of every 100 in sales, about −52 is left after running the business.
- Health Catalyst, Inc. lost $178M in fiscal 2025.
- Free cash flow was −$0.2M in fiscal 2025, −0.1% of revenue.
- Health Catalyst, Inc. returned $5.0M to shareholders in fiscal 2025. The diluted share count rose 16.1%.
- Health Catalyst, Inc. owes $57.5M more than it holds in cash.
Market cap
$125M
P/E
—
Revenue
$311M
Net income
−$178M
Free cash flow
−$0.2M
Operating margin
−51.7%
Health Catalyst, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+1.5%
Only a little. Sales grew 1.5% last year.
Does it make a profit?
−57.2%
No. It lost money last year.
Does profit turn into cash?
−0.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Health Catalyst, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 12, 2026
- Legal name
- Health Catalyst, Inc.
- CIK
- 0001636422
Health Catalyst, Inc. · HCAT
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $242M | $276M | $296M | $307M | $311M |
| Revenue growth | 28.1% | 14.2% | 7.1% | 3.6% | 1.5% |
| Operating margin | −59.4% | −50.7% | −42.9% | −22.8% | −51.7% |
| Net income | −$153M | −$137M | −$118M | −$69.5M | −$178M |
| Net margin | −63.3% | −49.7% | −39.9% | −22.7% | −57.2% |
| Diluted EPS | −$3.23 | −$2.63 | −$2.09 | −$1.15 | −$2.55 |
| Cash | |||||
| Cash from operations | −$23.1M | −$35.3M | −$33.1M | $14.6M | $0.7M |
| Capital expenditure | $10.5M | $2.2M | $1.2M | $1.6M | $1.0M |
| Free cash flow | −$33.6M | −$37.4M | −$34.3M | $12.9M | −$0.2M |
| FCF margin | −13.9% | −13.6% | −11.6% | 4.2% | −0.1% |
| Share buybacks | $0.0M | $8.4M | $1.8M | $0.0M | $5.0M |
| Share count change | 20.1% | 13.9% | 4.3% | 6.7% | 16.1% |
| Debt and strength | |||||
| Cash and short-term investments | $445M | $363M | $318M | $392M | $95.7M |
| Debt incl. finance leases | $181M | $227M | $228M | $382M | $153M |
| Shareholders' equity | $522M | $425M | $367M | $365M | $246M |
| Current ratio | 5.5x | 5.2x | 4.4x | 1.4x | 1.9x |
| Returns and quality | |||||
| Return on capital | −44.0% | −38.4% | −36.2% | −15.5% | −41.9% |
| Return on equity | −38.4% | −29.0% | −29.8% | −19.0% | −58.3% |
| Return on tangible equity | −61.9% | −93.6% | −114.8% | −358.3% | — |
| Piotroski F-score | 4 | 3 | 3 | 3 | 5 |
| Altman Z'' | 0.4 | −1.2 | −2.4 | −3.2 | −9.0 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$0.2M
2 insiders
Of sales under plans
36%
$0.1M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Health Catalyst, Inc. · HCAT
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.69 a share, the company is worth $125M.
Source: SEC EDGAR XBRL filings (CIK 0001636422). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.